All News #Library
Rare Diseases
EMA Grants Orphan Status To Kedrion`s Aceruloplasminemia
27 Nov 2025 //
PHARMIWEB
Kedrion COAGADEX Gets Orphan Drug Status for aFXD, Begins Trial
29 Jul 2025 //
PR NEWSWIRE
Kedrion Raises Awareness Around Plasminogen Deficiency
05 May 2025 //
PR NEWSWIRE
Kedrion Biopharma Ends 2024 With 10% Growth, Rebrands
14 Apr 2025 //
PR NEWSWIRE
Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in US
29 Apr 2024 //
PR NEWSWIRE

Market Place
Sourcing Support